The Pezcoller Foundation–AACR Scholar-in-Training grants
The AACR-Pezcoller Foundation Scholar-in-Training grants continue the AACR’s long-standing support of the next generation of cancer researchers, aimed:
- to enhance participation in the programs and activities of the AACR by early-career investigators residing in Europe
- to provide these outstanding Scholar-in-Training Awardees with an opportunity to share their research findings with the international cancer research community at the AACR Annual Meeting.
The Scholar-in-Training grants are highly competitive and recognize outstanding young investigators presenting meritorious papers at the AACR Annual Meeting’ poster exhibition.
ELIGIBILITY
- Applicants must be the first author and presenter of an abstract submitted for presentation at the Annual Meeting.
- Applicants must be an associate member of the AACR in good standing Nonmember graduate students, medical students and residents, clinical fellows or equivalent, and postdoctoral fellows who wish to apply for a Scholar-in-Training Award should first submit a membership application.
SELECTION
Successful applicants will be selected based on the merit of their abstract, CV, and personal statement; every effort will be made to notify awardees by the end of January.
Generally 5-6 of such fellowships are annually supported by the Pezcoller Foundation, to scientists in training who are travelling from Italy and Europe.
Those who may be interested to apply, or have any questions related to Scholar-in-Training Awards for the Annual Meeting, please email sita@aacr.org or visit Scholar-in-Training Awards.
President Galligioni with the 2025 AACR-Pezcoller Foundation Scholar-in-Training Awardees
Winners of the 2025 Pezcoller “Scholar-In-Training” grants
Luisa Amato (University of Campania “Luigi Vanvitelli,” Napoli, Italy) “Efficacy of DNA-PK inhibitor as maintenance strategy after cisplatin induction in SCLC”
Nanna Kristjansdottir (Aarhus University, Aarhus, Denamrk) “Low T cell diversity is associated with poor outcome in bladder cancer: A comprehensive longitudinal analysis of the T cell receptor repertoire”
Carmen Rubio Alarcon (Netherlands Cancer Institute, Amsterdam, The Netherlands) “Beyond tumor size: Biological and clinical predictors of ctDNA shedding in colon cancer”
Bisan Abdalfatah Zohud (Universitätsklinikum Erlangen, Erlangen, Germany) “Endothelial SPARCL1 suppresses colorectal cancer metastases through dormancy induction and EMT inhibition in colonizing tumor cells”
Martha Zylka (St. Anna Children’s Cancer Research Institute, Vienna, Austria) “A novel organoid-based model to study pediatric tumor metastasis to the lung”.